Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

NCT01244503 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

61

Enrollment

OTHER

Sponsor class

Stopped Budgetary Issues

Conditions

Metabolic Syndrome
Nonalcoholic Fatty Liver Disease

Interventions

DRUG: Sodium Octanoate Breath Test

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]